Nanoparticles for Cancer Targeting: Current and Future Directions

E-ISSN： 1875-5704|13|8|1290-1302

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.13, Iss.8, 2016-12, pp. : 1290-1302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PET/CT imaging in cancer: Current applications and future directions

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3433-3445

Blackwell Publishing

Access to resources Recommend Favorite

Docetaxel in the management of prostate cancer: current standard of care and future directions

By Dosso Sara De Berthold Dominik R

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1969-1979

Informa Healthcare

Access to resources Recommend Favorite

Targeted Approaches to Triple-Negative Breast Cancer: Current Practice and Future Directions

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 605-612

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy

Current Drug Metabolism, Vol. 17, Iss. 8, 2016-10 ,pp. : 755-762

Bentham Science Publishers

Access to resources Recommend Favorite